Remove Big Data Remove Gene Remove Genome Remove Genomics
article thumbnail

UK research partners team up to accelerate MND drug discovery

Drug Discovery World

Identifying genes linked with MND A key part of the MND Translational Challenge therapeutic strategy is to validate and de-risk MND targets using human genetic evidence. If we can identify the human genes linked to the condition it is more likely that treatments will succeed.

article thumbnail

Big data – charting a new path to drug discovery and development

Drug Discovery World

Drug discovery and development timelines can span 10-15 years or more from initial discovery to market approval and typically require the analysis of massive amounts of data. One system that has been especially useful in generating relevant and accurate biological data is the patient- derived xenograft (PDX) model for cancer studies.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New podcast: A deep dive into US drug discovery

Drug Discovery World

This is the latest episode of the free DDW narrated podcast, “What lies in the future for genomics and big data?”, ”, which covers two articles written for Volume 23, Issue 3 – Summer 2022 of DDW.

article thumbnail

The challenges and trends of cell & gene therapies 

Drug Discovery World

DDW Editor Reece Armstrong looks at the cell and gene therapy landscape, examining the challenges facing developers and the trends we can expect to see throughout the year. . There’s no doubt that cell and gene therapies present some of the most exciting opportunities for emerging drugs. million price point per dose.

article thumbnail

Meet the Researcher: Nicola McCarthy, Milner Therapeutics Institute

Drug Discovery World

NM: I think it’s moving into primary tissue, certainly for the wet lab work that we do on the arrayed functional genomics. It’s trying to get those models so that they can at least handle a substantial gene knockout set. NM: I think probably it’s big data.

article thumbnail

Vodcast: Nicola McCarthy, Milner Therapeutics Institute, at SLAS 2024

Drug Discovery World

NM: I think it’s moving into primary tissue, certainly for the wet lab work that we do on the arrayed functional genomics. It’s trying to get those models so that they can at least handle a substantial gene knockout set. NM: I think probably it’s big data.

article thumbnail

Bioinformatics Jobs: How to Succeed in This Competitive Space

XTalks

The Human Genome Project could not have succeeded without the use of bioinformatics. Since the conclusion of the project in 2003, bioinformatics tools have been used to identify genes and elucidate their function with the aim of developing gene-based strategies for disease prevention, diagnosis and treatment.